Italia markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
63,04-0,15 (-0,24%)
Al 1:21PM EDT. Mercato aperto.
Accedi per pubblicare un messaggio.
  • s
    stocktargetadvisor
    $GILD conversation
    $GILD
    Target Raised by Oppenheimer Holdings Outperform USD 90 » USD 105
  • I
    In
    $RLFTF conversation
    I've shorted some $GILD just to be on the safe side in case word gets out before markets open on Monday

    They also have an inhaler trial going on, but given the less than stellar results with Remdesivir that might even backfire if it's shown to have no benefit in inhaled form.
  • M
    Mumon
    Moleculin Biotech, Inc.
    ok $gild, I think you need to buy $mbrx .. cancer and covid/antivirals... right down your alley. $mbrx needs the speed that comes with your experience and deeper pockets. important treatments that are urgently needed.
  • I
    Itisme444
    At Phase 1 clinical trial, Ampion IV control group Covid-19 patients saw stronger clinical improvements than the Covid-19 standard care of control group, taking Remdesivir of $GILD

    From press release, “All patients treated with IV Ampion improved after treatment. At hospital discharge, the IV Ampion treatment group had a stronger clinical improvement than the COVID standard of care control group, as determined by both the World Health Organization ("WHO") clinical improvement scale1 and the National Early Warning Score ("NEWS2")”
  • a
    ageninrussia
    From AF:

    In 2016, $IMMU was a struggling $400M biotech when Avoro (then known as VenBio) went activist against the old management team.

    Today, sold to $GILD for $21B

    That’s how it’s done.
  • D
    David
    $OZSC conversation
    ((((( (( CELZ )) )))))
    Set to Explode.
    News 30 minutes ago.

    $CELZ $GILD $BNGO $AZN
  • I
    Itisme444
    What I understand Ampion IV was tested on severe Covid-19 patients with 85% or lower oxygen level for 5 days, and these patients saw immediate improvements in their oxygen levels! Lot better results than the $GILD treatment
  • B
    Blueberries
    $PFE conversation
    PFE green pre... ACRX is moving higher pre market on NEWS...
    long $teva $gild $azn $sava
  • D
    David
    $CELZ conversation
    CELZ Patent portfolio worth 2B!

    Buy now .OO3 or at $3.00

    $GILD $AZN $XELA $MSFT
  • D
    Dave
    $CYDY conversation
    We ask our officials to do the right thing. We should do the right thing as well by being strong advocates of Leronlimab. We can stay silent and chat about the SP or we can do something to make a difference. Please choose to make a difference and contact our officials, press, someone. Stay relentless my fiends - someone we don't know may be saved by your efforts.

    50 Patients Treated with Leronlimab - Many Recover
    https://www.targetedonc.com/view/close-to-50-patients-treated-with-leronlimab-for-covid-19-many-recover

    CBS News: Leronlimab ‘It Saved My Life’
    ‘It Saved My Life’: OC Woman Survives Coronavirus After Receiving Experimental Drug Leronlimab
    https://losangeles.cbslocal.com/2020/08/18/covid-19-survivor-coronavirus-experimental-drug-leronlimab/

    and FORBES took down this Article which first appeared on the same day as Trump's announcement of CP as a breakthrough.
    https://www.fr24news.com/a/2020/08/there-really-is-a-covid-therapy-that-works-it-is-called-leronlimab.html

    Why was the Forbes Article taken down?
    according to Thomas Landstreet the author @TomLandstreet·
    Aug 27
    (1) Forbes took my post on $CYDY Leronlimab down because they viewed my statements regarding the @realDonaldTrump presser misleading.
    I greatly appreciate all of the tremendous support I've received over the last few days. I continue to believe deeply in Leronlimab.

    Aug 27
    (2) I wrote the article because I, like many of you, have been tremendously disappointed by the government's response to Covid-19.
    I've done my work on HCQ, Remdesivir $GILD, and Plasma. No treatment on the market even comes close to Leronlimab re efficacy. AND it's safe. $cydy
    Thomas Landstreet

    Aug 27
    (3) It's time for our officials to approve Leronlimab for emergency usage - why should a patient die under standard of care when Leronlimab (with a perfect safety profile) could have saved them?
    The drug WORKS.
    “We believe these results, although anecdotal, are very impressive and the number of patients treated under eIND is rapidly increasing."
    “We believe these results, although anecdotal, are very impressive and the number of patients treated under eIND is rapidly increasing."
    www.targetedonc.com
  • W
    Whiteoak
    $CYDY conversation
    Forbes/Thomas Landstreet Update:
    For those following this. I had asked about this a day or two ago and now see Thomas tweeting the following explanation for why the Forbes article was taken down:

    "Thomas Landstreet
    @TomLandstreet
    ·
    46m
    (1) Forbes took my post on $CYDY Leronlimab down because they viewed my statements regarding the
    @realDonaldTrump
    presser misleading.

    I greatly appreciate all of the tremendous support I've received over the last few days. I continue to believe deeply in Leronlimab.
    Thomas Landstreet
    @TomLandstreet
    ·
    40m
    (2) I wrote the article because I, like many of you, have been tremendously disappointed by the government's response to Covid-19.

    I've done my work on HCQ, Remdesivir $GILD, and Plasma. No treatment on the market even comes close to Leronlimab re efficacy. AND it's safe. $cydy
    Thomas Landstreet
    @TomLandstreet
    ·
    46m
    (3) It's time for our officials to approve Leronlimab for emergency usage - why should a patient die under standard of care when Leronlimab (with a perfect safety profile) could have saved them?

    The drug WORKS. "

    Read More: https://investorshangout.com/post/view?id=5876567#ixzz6WPsp2AAF

    Read More: https://investorshangout.com/post/view?id=5876567#ixzz6WPsG35Oh
    CYDY CytoDyn Inc: Forbes/Thomas Landstreet Update: For those following this. I had asked about this a day or two ago - #5876567
    CYDY CytoDyn Inc: Forbes/Thomas Landstreet Update: For those following this. I had asked about this a day or two ago - #5876567
    investorshangout.com
  • M
    Michael
    $CYDY conversation
    Thomas Landstreet hasn't forgotten us!

    $CYDY Leronlimab vs. $GILD Remdesivir; David vs. Golliath
  • D
    David
    $CELZ conversation
    Only hope is that CELZ CEO has been collecting CELZ shares in open market!!

    $GILD
  • D
    David
    $CELZ conversation
    All Patents in place now! BUYOUT is any day!!! They've been collecting Patents just to sell!! $1.00 min be we think closer to $2.00 per share ALL stock transaction. Warb already has a connection with GILD. Buyout is this year.

    $GILD
  • T
    Tim
    This quote is only one of many from Microcap Daily.....

    “Of course $GILD overpaid for $IMMU given $NWBO will possibly make Trodelvy obsolete.”
  • U
    US Stock BUBBLE 2020
    $C conversation
    US STOCKS WILL COLLAPSE MASSIVELY! MAJOR CORRECTION IS COMING!
    It is not secret to anyone that the US Stock Market is a FRAUDULENT system. The US Government PRINTS Money and buy the Stocks via the infinite margin trading desks to PUMP the Prices. However, this FRAUDULENT system, which is designed to make insiders “QUICK RICH”, is NOT Sustainable.
    US Stock Valuations are IMPOSSIBLE to justify! US Stocks are EXTREMELY OVERVALUED and OVERBOUGHT! The Market is in the Tulip Mania BUBBLE!
    The Government is PUMPING Various stocks in various industries every single day, FOR NO REASON. At some days, the “Lucky” stocks and sectors are financials, the other days “online services”.
    DESPITE COLLAPSING Economy, Tanking Corporate revenues and earnings, growing Corporate LOSS, Skyrocketing inflation, Skyrocketing unemployment, Astronomical Corporate and National Debt, ABSURD Valuations, Worsening Trade War and Spreading Coronavirus Pandemic, the US Government is PUMPING the US Stock Prices, the MEGA BUBBLE Every single day!
    CHASERS WILL BURN HARD soon!
    $AMD $NVDA $AMZN $AAPL $SQ $SHOP $SNAP $TWLO $CRM $ROKU $ADBE $DB $BAC $JPM $MS $GS $TWTR $TSLA $IBM $INTC $MSFT $GOOG $LMT $BA $TXN $NXPI $LRCX $NKE $DIS $EBAY $X $MA $V $S $T $F $GM $NFLX $CSCO $CAT $MMM $SBUX $TGT $WMT $ATVI $EA $TTWO $MCD $AVGO $JNJ $BIDU $BZUN $BABA $MU $AMAT $QCOM $WFC $BBBY $PFE $GE $WDC $BLK $KO $UA $ABBV $GILD $BB $ORCL $RH $KEM $IQ $GRPN $PYPL $MA $MOMO $JD $WBA $CVS $FB $W $BBY $SKX $FL $EFX $ETSY $W $UNH $SAP $GPRO $KHC $DPZ $PEP $LYFT $UBER $BYND $ZM $OLED $XOM $CVX $DAL $UAL $AAL $LUV $SAVE $AXP $SPCE $NCLH $CCL $NKLA $NIO
    https://www.cnbc.com/2020/09/18/barclays-says-market-valuations-at-dotcom-bubble-levels-downgrades-large-tech-stocks.html
    Barclays downgraded the megacap technology sector to market weight given their stretched valuations.
    Barclays downgraded the megacap technology sector to market weight given their stretched valuations.
    www.cnbc.com
  • D
    David
    $POAI conversation
    POAI, CELZ, BNGO,

    5 BAGGER 100 BAGGER 10 BAGGER

    $CELZ $GILD $BNGO
  • s
    stocktargetadvisor
    $GILD conversation
    $GILD
    Reiterated by Raymond James Financial Hold 2020-09-14
    Maintains SVB Leerink Outperform USD 94 » USD 88
  • s
    stocktargetadvisor
    $GILD conversation
    $GILD
    Upgraded by Maxim Group Hold » Buy USD 88
    Target Lowered by RBC Capital Outperform USD 84 » USD 82
  • D
    David
    $CELZ conversation
    CELZ going up 12,000%

    $GILD $AZN $MSFT $BNGO
Usando Yahoo accetti che Yahoo e i suoi partners utilizzino cookies per fini di personalizzazione e altre finalità